YawaMed's novel approach to treat Deep Vein Thrombosis and Pulmonary Emboli-Gerardo Noriega-08/01/2017 - 8:30am

Event Information
Event Topic: 
YawaMed's novel approach to treat Deep Vein Thrombosis and Pulmonary Emboli
Event Date: 
08/01/2017 - 8:30am
Event Location: 
Sunnyvale City Council Chambers- 456 West Olive Ave., Sunnyvale
Speaker Information
Event Speaker: 
Gerardo Noriega
Event Speaker Title: 
Managing Director
Event Speaker Company: 
Event Speaker Bio: 

Mr. Noriega is a serial entrepreneur, inventor and scholar in the Medical Device Industry. He is the Founder of three medical devices companies and consultant to over 50 companies in the Silicon Valley.

As a serial entrepreneur, he identifies unmet clinical needs, assesses new business opportunities worldwide and develops new technologies with strong Intellectual property rights. His hands-on experience resides in bringing new technologies from inception to full commercialization under the “Vision and Execution” type of approach.

Our unique close proximity to Silicon Valley provides a wealth of opportunities for innovation like no other place in the world. He is always on the quest for the next frontier to improve clinical therapies and
reduce healthcare cost.

His expertise resides in developing novel technologies in the following areas:
Cardiovascular (Intravascular and intracardiac drug delivery, implants and diagnostic devices), Peripheral vasculature (Arterial and venous devices therapeutic and diagnostic), Neurovascular (Minimally invasive drug delivery and implant devices), COPD (Diagnostic and therapeutic minimally invasive devices and implants), Ophthalmic (Implants), Urology (Transurethral minimally invasive devices and diagnostics), Gynecology (Transurethral minimally invasive therapeutic devices, implants and diagnostic devices), Robotics (Minimally invasive surgery, nanotechnology devices), Odontology (Minimally invasive devices), and Obesity (Minimally invasive devices and implants).

Event Details
Event Details: 

In the United States, approximately 600,000 people have a pulmonary embolism each year, and about 30% of them die. Pulmonary embolism (PE) occurs when a blood clot detaches from a larger thrombus located somewhere else in the body (frequently from DVT, or Deep Vein Thrombosis), becoming an embolus, and travels into the heart via the inferior or superior vena cava. This embolus then travels through the heart and into the pulmonary trunk, arteries, or branches where it becomes lodged. This foreign body blocks the deoxygenated blood returning from the body from reaching the main oxygen supply in the lungs. Consequently, the blood cannot be re-oxygenated, and therefore, depletes the body from the proper amount of oxygen needed to fulfill normal functions. The proposed YawaMed approach is to treat DVT by removing the clot that is attached to the vessel wall as well as the main thrombus core structure. Studies demonstrated that mechanical removal of the clot improves venous valve function preservation. Achieving this goal minimizes deaths and complications in pulmonary embolism and diminishes the sequelae of post-thrombotic syndrome. This talk will review the clinical background of DVT and discuss YawaMed's novel approach to treating this disease state.